Animal Model Market : Key companies Profile, their market Share | Transposagen Biopharmaceuticals, Inc., Envigo CRS SA, Crown Bioscience, Inc

According to a recently compiled study by Future Market Insights, the global animal model market will reflect an impressive CAGR through the forecast period, 2017 to 2026. Revenues from the global market for animal model are poised to surpass US$ 2,200 Mn by 2026-end.

Leveraging Animal Models offers Better Understanding of Different Diseases

Animals and human beings share a common biological as well as physiological structure. Animals possess shorter life cycle, however they have high genotype resemblance. It is simple and easy to control the animal environment as compared to the human beings. The animal models are increasingly being used in the biomedical research that helps to develop new treatment methods for various diseases. Leveraging animal models offers a better understanding of different diseases, along with the efficacy of drugs with regard to the diseases. Owing to these factors, demand for animal models has been witnessing a significant surge in the healthcare sector. Alternatives such as cell cultures, tissue cultures, and computer models are also available, however animal models are more preferred owing to the complexity of the living systems. This further makes animal models an effective choice for biomedical research.

Request to View a Sample Copy of This Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3141

Development of animal models, which are more predictive in being effective is an iterative process. However, progress is being made, with researchers applying new experimental approaches to elucidate the biology of specific diseases for the creating of new and efficient animal models. During the development of new drugs dedicated to complex diseases, researchers are being well advised for testing drugs in multiple animal models as well as in mouse strains with different genetic backgrounds. Researchers are also focusing on employing translational efficacy or pharmacodynamic biomarkers for linking efficacy observed in clinical results with pre-clinical analyses.

Key Takeaways from FMI’s Report on Global Animal Model Market

North America is expected to remain the largest and fastest expanding market for animal model, with revenues estimated to surpass US$ 800 Mn by 2026-end. Between animal model markets in Asia-Pacific and Europe, the former will account for relatively larger revenue share, whereas the latter will expand at a comparatively higher CAGR through 2026. Although the market in South Korea will account for the lowest market revenue share, revenues are projected to expand at a relatively higher CAGR than those from the markets in Latin America and Middle East & Africa (MEA) through 2026.

On the basis of species, revenues from rats and mice are projected to account for over two-fifth share of the market by 2026-end. Revenues from use of rats in animal models will expand at the highest CAGR in the market through 2026. In addition, revenues from use of cats and monkeys in animal models will rise at a nearly equal CAGR through 2026. Dogs and pigs are expected to remain the least lucrative species used in animal models during the forecast period.

Contract research organizations (CROs) and biotechnology companies are anticipated to remain the fast expanding end-users of animal models. Revenues from these two end-users are collectively forecast to surpass US$ 850 Mn by 2026-end. In terms of revenues, academic & research institutions and pharmaceutical companies will continue to be dominant end-users in the global animal model market.

Basic and applied research application of animal model will continue to register the fastest expansion through 2026. However, drug discovery/development will remain the most lucrative application of animal model.’

Request to Browse Report Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-3141

Key companies actively contributing to growth of the global animal model market include Transposagen Biopharmaceuticals, Inc., Envigo CRS SA, Crown Bioscience, Inc., Eurofins Scientific SE, Genoway SA, Taconic Biosciences, Inc., Trans Genic Inc, The Jackson Laboratory, Horizon Discovery Group plc, and Charles River Laboratories International, Inc.

Animal Model Market Reports - Table of Contents
1. Global Economic Outlook

2. Global Animal Model Market - Executive Summary

3. Global Animal Model Market Overview

3.1. Introduction

3.1.1. Global Animal Model Market Taxonomy

3.1.2. Global Animal Model Market Definition

3.2. Global Animal Model Market Size (US$ Mn) and Forecast, 2012-2026

3.2.1. Global Animal Model Market Y-o-Y Growth

3.3. Global Animal Model Market Dynamics

3.4. Global Animal Model Market Attractiveness By Region

3.5. Supply Chain

3.6. Cost Structure

3.7. Types of Animal Models

3.8. Animal Models in Disease Research

3.9. Regulatory Scenario in Animal Model

3.10. Product Life Cycle

3.11. PESTL Analysis

3.12. Technology Roadmap of Animal Model

3.13. Designing an Animal Model for Clinical Research

3.14. Number of Animals Used for Research and Testing Worldwide

3.15. Number of Animal Used for Research in South Korea (2008 – 2016)

3.16. Research and Development (R&D) Investment Country – Wise

3.17. List of Distributors

3.18. Key Participants Market Presence (Intensity Map) By Region

4. Global Animal Model Market Analysis and Forecast 2012-2026

4.1. Global Animal Model Market Size and Forecast By Species, 2012-2026

4.1.1. Rats Market Size and Forecast, 2012-2026

4.1.1.1. Revenue (US$ Mn) Comparison, By Region

4.1.1.2. Market Share Comparison, By Region

4.1.1.3. Y-o-Y growth Comparison, By Region

4.1.2. Mice Market Size and Forecast, 2012-2026

4.1.2.1. Revenue (US$ Mn) Comparison, By Region

4.1.2.2. Market Share Comparison, By Region

4.1.2.3. Y-o-Y growth Comparison, By Region

4.1.3. Guinea Pig Market Size and Forecast, 2012-2026

4.1.3.1. Revenue (US$ Mn) Comparison, By Region

4.1.3.2. Market Share Comparison, By Region

4.1.3.3. Y-o-Y growth Comparison, By Region

4.1.4. Rabbits Market Size and Forecast, 2012-2026

4.1.4.1. Revenue (US$ Mn) Comparison, By Region

4.1.4.2. Market Share Comparison, By Region

4.1.4.3. Y-o-Y growth Comparison, By Region

4.1.5. Monkeys Market Size and Forecast, 2012-2026

4.1.5.1. Revenue (US$ Mn) Comparison, By Region

4.1.5.2. Market Share Comparison, By Region

4.1.5.3. Y-o-Y growth Comparison, By Region

4.1.6. Dogs Market Size and Forecast, 2012-2026

4.1.6.1. Revenue (US$ Mn) Comparison, By Region

4.1.6.2. Market Share Comparison, By Region

4.1.6.3. Y-o-Y growth Comparison, By Region

4.1.7. Pigs Market Size and Forecast, 2012-2026

4.1.7.1. Revenue (US$ Mn) Comparison, By Region

4.1.7.2. Market Share Comparison, By Region

4.1.7.3. Y-o-Y growth Comparison, By Region

4.1.8. Cats Market Size and Forecast, 2012-2026

4.1.8.1. Revenue (US$ Mn) Comparison, By Region

4.1.8.2. Market Share Comparison, By Region

4.1.8.3. Y-o-Y growth Comparison, By Region

4.1.9. Other Species Market Size and Forecast, 2012-2026

4.1.9.1. Revenue (US$ Mn) Comparison, By Region

4.1.9.2. Market Share Comparison, By Region

4.1.9.3. Y-o-Y growth Comparison, By Region

To Know More Clear Details about This Report, Ask The Analyst: https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-3141

Contact Us

U.S. Office

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

Email: sales@futuremarketinsights.com

Web: https://www.futuremarketinsights.com/

About Us

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

This release was published on openPR.